Incyte Corp. (INCY)
115.71
-1.22
(-1.04%)
USD |
NASDAQ |
Oct 23, 16:00
115.60
-0.11
(-0.10%)
After-Hours: 20:00
Incyte Price : 115.71 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 116.75 | 116.86 | 115.12 | 115.71 | 1.477M |
| Oct 22, 2026 | 113.93 | 117.17 | 112.76 | 116.93 | 2.236M |
| Oct 21, 2026 | 115.98 | 116.57 | 113.35 | 113.44 | 1.405M |
| Oct 20, 2026 | 113.78 | 117.00 | 113.26 | 116.62 | 1.342M |
| Oct 19, 2026 | 113.19 | 114.38 | 112.71 | 113.25 | 1.190M |
| Oct 16, 2026 | 113.98 | 114.57 | 112.02 | 113.07 | 1.581M |
| Oct 15, 2026 | 112.71 | 116.03 | 112.60 | 113.27 | 1.940M |
| Oct 14, 2026 | 108.61 | 112.06 | 107.83 | 111.57 | 1.870M |
| Oct 13, 2026 | 111.29 | 111.68 | 107.78 | 108.62 | 2.590M |
| Oct 12, 2026 | 114.05 | 114.05 | 111.26 | 111.36 | 1.479M |
| Oct 09, 2026 | 112.35 | 113.87 | 111.80 | 112.79 | 1.122M |
| Oct 08, 2026 | 112.89 | 113.75 | 110.08 | 112.75 | 1.927M |
| Oct 07, 2026 | 112.82 | 115.49 | 112.46 | 113.44 | 1.275M |
| Oct 06, 2026 | 114.13 | 114.97 | 111.67 | 112.73 | 2.460M |
| Oct 05, 2026 | 115.14 | 115.67 | 112.83 | 114.13 | 1.949M |
| Oct 02, 2026 | 116.76 | 117.19 | 114.57 | 115.30 | 2.170M |
| Oct 01, 2026 | 120.47 | 121.22 | 117.00 | 117.14 | 2.365M |
| Sep 30, 2026 | 123.00 | 124.23 | 121.03 | 121.35 | 1.620M |
| Sep 29, 2026 | 123.67 | 125.47 | 121.89 | 123.20 | 1.719M |
| Sep 28, 2026 | 123.32 | 126.14 | 122.53 | 124.82 | 1.436M |
| Sep 25, 2026 | 125.72 | 126.00 | 123.07 | 123.89 | 1.210M |
| Sep 24, 2026 | 124.79 | 125.55 | 123.03 | 124.44 | 1.405M |
| Sep 23, 2026 | 127.51 | 128.21 | 123.89 | 124.64 | 1.534M |
| Sep 22, 2026 | 124.72 | 127.75 | 124.01 | 126.93 | 1.647M |
| Sep 21, 2026 | 125.00 | 127.41 | 124.19 | 124.65 | 1.271M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Mirum Pharmaceuticals, Inc. | 80.39 |
| Regeneron Pharmaceuticals, Inc. | 805.02 |
| AbbVie, Inc. | 285.64 |
| Alnylam Pharmaceuticals, Inc. | 224.03 |
| Biogen, Inc. | 250.69 |
Price Related Metrics
| PE Ratio | 14.75 |
| PS Ratio | 4.082 |
| PEG Ratio | 0.1881 |
| Price to Book Value | 3.665 |
| Price to Free Cash Flow | 12.57 |
| Earnings Yield | 6.78% |
| Market Cap | 23.26B |
| PEGY Ratio | 0.1881 |
| Operating PE Ratio | 12.91 |
| Normalized PE Ratio | 14.52 |